4 Recruiting Gastrointestinal Stromal Tumors Phase 2 Clinical Trials
Active phase 2 studies for gastrointestinal stromal tumors enrolling across the USA. Verify eligibility and contact site coordinators.
All Gastrointestinal Stromal Tumors studiesPhase 2 Studies for Gastrointestinal Stromal Tumors
🔵 Active, Not Recruiting Phase2
SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST
📍 Sylvester Comprehensive Cancer Center, University of Miami — Miami, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2
Imatinib TDM in GIST
📍 Markey Cancer Center — Lexington, Kentucky
View Study & Checklist ➔